Compensation 990

Lovelace Biomedical Research Institute

Fiscal year ending 2024. Filed on May 12, 2025.

2425 Ridgecrest Drive SE
Albuquerque, New Mexico 87108

Lovelace Biomedical Research Institute (EIN: 85-0110669) has filed an IRS Form 990 between fiscal years 2017 and 2024. In its fiscal year 2024 IRS Form 990 filing, Lovelace Biomedical Research Institute, a 501(c)(3) charitable organization, reported compensation for 12 out of 531 total employees. Among the employees shown here, the average compensation is $505,856. The highest compensated employee at Lovelace Biomedical Research Institute is Alan Kadish with fiscal year 2024 compensation of $1,169,210.

Revenue, expenses, and employee compensation

Revenue

$91,209,797

Expenses

$91,486,502

Employee compensation

$36,877,596
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

New in 2024
Alan Kadish
Board Chair and President
$1,169,210
$0 from org$1,049,960 from related$119,250 other
－1.3%vs 2023
Robert W Rubin, Ph.D.
CEO, Advisory Non-Voting Director
$941,935
$874,428 from orgNo related comp$67,507 other
＋7.7%vs 2023
Shannon L Toma
Treasurer, Executive Vice President, COO, CFO
$761,198
$713,675 from orgNo related comp$47,523 other
New in 2024
Steven A Belinsky
Vice President Academic Research/Sr Scientist
$451,191
$404,462 from orgNo related comp$46,729 other
＋8.0%vs 2023
Kent Kiehl
Executive Science Officer
$430,054
$386,988 from orgNo related comp$43,066 other
New in 2024
Nicholas S Janiga
Special Appointee
$424,759
$0 from org$345,982 from related$78,777 other
＋10.2%vs 2023
David M Flanders
Vice President, Human Resources
$353,605
$314,924 from orgNo related comp$38,681 other
New in 2024
Matthew F Bonilla
Special Appointee
$345,129
$0 from org$300,777 from related$44,352 other
－17.5%vs 2023
Jacob D McDonald
Vice President Applied Science (Thru 9/7/2023)
$328,817
$287,941 from orgNo related comp$40,876 other
＋11.8%vs 2023
Andrew R Mayer
Vice President of Interdisciplinary Science
$324,295
$282,904 from orgNo related comp$41,391 other
＋9.4%vs 2023
Edward G Barrett
SR Director of Pharmacology
$313,220
$268,562 from orgNo related comp$44,658 other
New in 2024
Wanda Hernandez
Special Appointee
$226,858
$0 from org$195,253 from related$31,605 other

Non-Employee Board Members

Jackie Lovelace Johnson
Chairwoman of the Board, Directors
Jane Delgado
Director VICE Chair NOM Committee
Jospeh D Mark
Director
Lawrence D Platt
Director
Margaret Retter
Director
Zvigmond Ryzman
Director

Mission Statement

THE LOVELACE BIOMEDICAL RESEARCH INSTITUTE (LBRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF DISEASES. LBRI IS DEDICATED TO THE DISCOVERY AND ADVANCEMENT OF CLINICAL SOLUTIONS FOR PREVENTION, DIAGNOSIS, TREATMENT AND CURING DISEASES THROUGH RESEARCH. THE RESEARCH IS AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY, NEUROLOGICAL AND OTHER HEALTH HAZARDS; MENTAL ILLNESS; TRAUMATIC BRAIN INJURY AND OTHER BRAIN DISORDERS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LBRI IS BASED IN ALBUQUERQUE, NEW MEXICO.

Revisions to this organization profile

May 12, 2025:
2024 Lovelace Biomedical Research Institute 990 filed
February 21, 2024:
2023 Lovelace Biomedical Research Institute 990 filed
March 25, 2023:
2022 Lovelace Biomedical Research Institute 990 filed

Get an email when new compensation information is released for Lovelace Biomedical Research Institute

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →